BD NEXIVA CLOSED IV CATHETER SYSTEM SINGLE PORT 18 GA 1.25 IN
Report
- Report Number
- 1710034-2021-00183
- Event Type
- Malfunction
- Date Received
- March 11, 2021
- Date of Event
- February 12, 2021
- Report Date
- April 6, 2021
- Manufacturer
- BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
- Product Code
- FOZ
- PMA / PMN Number
- K102520
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
INVESTIGATION SUMMARY : OUR QUALITY ENGINEER INSPECTED THE PHOTOGRAPHS SUBMITTED FOR EVALUATION. BD RECEIVED TWO PHOTOS SHOWING A USED UNIT WITH TRACES OF THICK MEDIA THROUGHOUT THE UNIT. INSPECTION OF THE PROVIDED PHOTO REVEALED THAT THE NEEDLE HAD PIERCED THROUGH THE CATHETER TUBING NEAR THE TIP, CONFIRMING THE REPORTED DEFECT OF NEEDLE THROUGH CATHETER. THIS TYPE OF DEFECT CAN OCCUR DURING THE MANUFACTURING PROCESS OR IN THE CLINICAL SETTING. THE PRESENCE OF MEDIA THROUGHOUT THE UNIT, INCLUDING THE TIP OF THE CATHETER TUBING, INDICATED THAT THE NEEDLE AND CATHETER WERE CORRECTLY ASSEMBLED AT THE TIME OF VENIPUNCTURE. TYPICALLY, IF THE DEFECT WERE MANUFACTURING RELATED THE USER WOULD NOTICE THE DEFECT BEFORE VENIPUNCTURE AND IF VENIPUNTURE WAS ATTEMPTED IT WOULD HAVE BEEN VERY DIFFICULT, EVEN PAINFUL WITH THE CATHETER TIP FOLDING DURING THE ATTEMPT. BASED ON THIS EVIDENCE, THE ROOT CAUSE IS LIKELY RELATED TO RECANNULATION DURING USE. A DEVICE HISTORY RECORD REVIEW SHOWED NO NON-CONFORMANCES ASSOCIATED WITH THIS ISSUE DURING THE PRODUCTION OF THIS BATCH.
IT WAS REPORTED THAT THE BD NEXIVA¿ CLOSED IV CATHETER SYSTEM ¿ SINGLE PORT 18 GA 1.25 IN EXPERIENCED NEEDLE PIERCING THROUGH THE CATHETER DURING INTRODUCTION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: 383519, BATCH NO: 0233429. I AM STILL HEARING A LOT OF CONCERN REGARDING THE FLOW RATES OF THE NEW COMPARED TO THE OLD. WE WERE TOLD THAT THERE WAS NO MAJOR CHANGE, HOWEVER, WE ARE EXPERIENCING THE POWER INJECTORS PRESSURING OUT OR SLOWING DOWN MORE. WE HAVE SOME EXAMS USING OMNIPAQUE 350 THAT NEED TO GO UP TO 6-7 ML/SEC WITH AN 18 GA, BD MAX IS 4.5-5. THEY ARE FEELING A LITTLE ¿TURBULENCE¿ AND HAVE NOTICED ON THE INJECTOR SEEMS TO SLOW DOWN AND THEN SPEED BACK UP. WE WERE NOT ABLE TO GET THE CLEAR CAP ON THE END OF THE TUBING OFF OF AN 18G BD CATHETER (LOT # 0233429). WE HAD TO RE-STICK THE PATIENT WITH ANOTHER 18G. ANOTHER NURSE REPORTED THE NEEDLE GOING THROUGH THE CATH INSIDE THE PATIENT.
DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD.. THE CUSTOMER'S ADDRESS IS UNKNOWN: (B)(6) HAS BEEN USED AS A DEFAULT.¿ A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.
IT WAS REPORTED THAT THE BD NEXIVA" CLOSED IV CATHETER SYSTEM SINGLE PORT 18 GA 1.25 IN EXPERIENCED NEEDLE PIERCING THROUGH THE CATHETER DURING INTRODUCTION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO: 383519, BATCH NO: 0233429. I AM STILL HEARING A LOT OF CONCERN REGARDING THE FLOW RATES OF THE NEW COMPARED TO THE OLD. WE WERE TOLD THAT THERE WAS NO MAJOR CHANGE, HOWEVER, WE ARE EXPERIENCING THE POWER INJECTORS PRESSURING OUT OR SLOWING DOWN MORE. WE HAVE SOME EXAMS USING OMNIPAQUE 350 THAT NEED TO GO UP TO 6-7 ML/SEC WITH AN 18 GA, BD MAX IS 4.5-5. THEY ARE FEELING A LITTLE TURBULENCE AND HAVE NOTICED ON THE INJECTOR SEEMS TO SLOW DOWN AND THEN SPEED BACK UP. WE WERE NOT ABLE TO GET THE CLEAR CAP ON THE END OF THE TUBING OFF OF AN 18G BD CATHETER (LOT # 0233429). WE HAD TO RE-STICK THE PATIENT WITH ANOTHER 18G. ANOTHER NURSE REPORTED THE NEEDLE GOING THROUGH THE CATH INSIDE THE PATIENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 359206 | BD NEXIVA CLOSED IV CATHETER SYSTEM SINGLE PORT 18 GA 1.25 IN | INTRAVASCULAR CATHETER | FOZ | BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. | 0233429 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 |